FDA panel backs gene therapy for rare form of blindness

loading...


FDA panel backs gene therapy for rare form of blindness
(Reuters) – Spark Therapeutics Inc’s experimental gene therapy for a rare form of blindness improves vision and should be approved, advisers to the Food and Drug Administration concluded on Thursday, paving the way for the first U.S. gene therapy for an inherited disease.


Source: Health And Fitness

Reply

Pin It on Pinterest

Shares
Share This
loading...